Skin Clearance, Duration of Treatment-free Interval, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-week Phase 3 Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s553, 2025. DOI: 10.25251/skin.10.supp.553. Disponível em: https://skin.dermsquared.com/skin/article/view/3285. Acesso em: 1 may. 2026.